Anti-SLC35A2 monoclonal antibody

Pre-made anti-SLC35A2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC35A2/SLC35A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1701-Ab-1/ GM-Tg-hg-IP1701-Ab-2Anti-Human SLC35A2 monoclonal antibodyHuman
GM-Tg-rg-IP1701-Ab-1/ GM-Tg-rg-IP1701-Ab-2Anti-Rat SLC35A2 monoclonal antibodyRat
GM-Tg-mg-IP1701-Ab-1/ GM-Tg-mg-IP1701-Ab-2Anti-Mouse SLC35A2 monoclonal antibodyMouse
GM-Tg-cynog-IP1701-Ab-1/ GM-Tg-cynog-IP1701-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC35A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1701-Ab-1/ GM-Tg-felg-IP1701-Ab-2Anti-Feline SLC35A2 monoclonal antibodyFeline
GM-Tg-cang-IP1701-Ab-1/ GM-Tg-cang-IP1701-Ab-2Anti-Canine SLC35A2 monoclonal antibodyCanine
GM-Tg-bovg-IP1701-Ab-1/ GM-Tg-bovg-IP1701-Ab-2Anti-Bovine SLC35A2 monoclonal antibodyBovine
GM-Tg-equg-IP1701-Ab-1/ GM-Tg-equg-IP1701-Ab-2Anti-Equine SLC35A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1701-Ab-1/ GM-Tg-hg-IP1701-Ab-2; GM-Tg-rg-IP1701-Ab-1/ GM-Tg-rg-IP1701-Ab-2;
GM-Tg-mg-IP1701-Ab-1/ GM-Tg-mg-IP1701-Ab-2; GM-Tg-cynog-IP1701-Ab-1/ GM-Tg-cynog-IP1701-Ab-2;
GM-Tg-felg-IP1701-Ab-1/ GM-Tg-felg-IP1701-Ab-2; GM-Tg-cang-IP1701-Ab-1/ GM-Tg-cang-IP1701-Ab-2;
GM-Tg-bovg-IP1701-Ab-1/ GM-Tg-bovg-IP1701-Ab-2; GM-Tg-equg-IP1701-Ab-1/ GM-Tg-equg-IP1701-Ab-2
Products NameAnti-SLC35A2 monoclonal antibody
Formatmab
Target NameSLC35A2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC35A2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1701-Ag-1Recombinant multi-species S35A2/ SLC35A2/ CDG2M protein
    ORF Viral VectorpGMLPm003544mouse Slc35a2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003544mouse Slc35a2 Lentivirus particle


    Target information

    Target IDGM-IP1701
    Target NameSLC35A2
    Gene ID7355,22232,100158233,711587,403595,101097792,338042,100051858
    Gene Symbol and SynonymsCDG2M,CDGX,Had-1,Had1,Sfc8,SLC35A2,UDP-Gal-Tr,UGALT,UGAT,UGT,UGT1,UGT2,UGTL
    Uniprot AccessionP78381,Q8WMS0,Q58DA6
    Uniprot Entry NameS35A2_HUMAN,S35A2_CANLF,S35A2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102100
    Target ClassificationN/A

    The target: SLC35A2, gene name: SLC35A2, also named as CDG2M, CDGX, UDP-Gal-Tr, UGALT, UGAT, UGT, UGT1, UGT2, UGTL. This gene encodes a member of the nucleotide-sugar transporter family. The encoded protein is a multi-pass membrane protein. It transports UDP-galactose from the cytosol into Golgi vesicles, where it serves as a glycosyl donor for the generation of glycans. Mutations in this gene cause congenital disorder of glycosylation type IIm (CDG2M). Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.